1. Home
  2. AMRX vs FOUR Comparison

AMRX vs FOUR Comparison

Compare AMRX & FOUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$13.08

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Logo Shift4 Payments Inc.

FOUR

Shift4 Payments Inc.

HOLD

Current Price

$44.25

Market Cap

3.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMRX
FOUR
Founded
2002
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.7B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
AMRX
FOUR
Price
$13.08
$44.25
Analyst Decision
Strong Buy
Buy
Analyst Count
5
22
Target Price
$15.60
$79.05
AVG Volume (30 Days)
1.4M
1.4M
Earning Date
05-01-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
157.89
N/A
EPS
0.19
N/A
Revenue
N/A
$4,180,000,000.00
Revenue This Year
$4.48
$23.83
Revenue Next Year
$7.13
$14.30
P/E Ratio
$68.18
$27.53
Revenue Growth
N/A
25.50
52 Week Low
$7.07
$39.61
52 Week High
$15.42
$107.16

Technical Indicators

Market Signals
Indicator
AMRX
FOUR
Relative Strength Index (RSI) 57.73 52.19
Support Level $12.45 $43.56
Resistance Level $13.64 $51.14
Average True Range (ATR) 0.34 2.16
MACD 0.07 0.35
Stochastic Oscillator 88.00 87.03

Price Performance

Historical Comparison
AMRX
FOUR

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About FOUR Shift4 Payments Inc.

Shift4 Payments Inc is an independent provider of software and payment processing solutions in the U.S., expanding internationally. Its payments platform offers integrated products and services across in-store, online, mobile and tablet-based channels, including end-to-end payment processing, merchant acquiring services, a proprietary omni-channel gateway, eCommerce capabilities, and reporting tools. The company distributes its services through internal sales teams and partners, including independent software vendors (ISVs) and value-added resellers (VARs). Revenue is predominantly recurring, derived mainly from processing fees and subscription revenue from POS software, business intelligence tools and other technology solutions. The company derives maximum revenue from the United States.

Share on Social Networks: